Novelty in the Target Landscape of the Pharmaceutical Industry

Nature argues that too much overlap in drug discovery research can be detrimental to the pharmaceutical industry, as the failure of one project can cause failures across the entire spectrum. At the same time, though, too little overlap can have the same effect, as multiple research targets increase scientific understanding.
Nature